GE HealthCare Carescape Canvas Cleared for Patient Monitoring

The FDA has granted 510(k) clearance to GE HealthCare’s Carescape Canvas patient monitoring platform.

The device uses micromodules (very small-scale electronic modules) that connect with standard medical USB technology and allows adding or disconnecting cables to devices such as for monitoring blood pressure, respiration, blood oxygen levels, heart rate and ECG.

The system enables hospitals to have a “single unified approach to patient monitoring that can easily tailored for each patient,” the company said.

Carescape Canvas was approved for use in the EU in June 2022.

Related Topics